« Back to Research Deepdives

Diabetes Prevention: Drugs vs. Lifestyle

This content is restricted to members.

To view our premium content, sign up for a membership:

 

Register New Account

Choose your membership level

Choose Your Payment Method

‹ Back to Research Deepdives

References

  1. DeFronzo R. Pathogenesis of Type 2 Diabetes. Drugs. 1999;58(Supplement 1):29-30.
  2. DeFronzo R, Eldor R, Abdul-Ghani M. Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes. Diabetes Care. 2013;36(Supplement_2):S127-S138.
  3. Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes A, Aribisala B et al. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. Cell Metabolism. 2018;28(4):667.
  4. Pan X, Li G, Hu Y, Wang J, Yang W, An Z et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544.
  5. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289-297.
  6. Tuomilehto J, Lindström J, Eriksson J, Valle T, Hämäläinen H, Ilanne-Parikka P et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine. 2001;344(18):1343-1350.
  7. Gillett M, Royle P, Snaith A, Scotland G, Poobalan A, Imamura M et al. Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technology Assessment. 2012;16(33).
  8. Natali A, Ferrannini E. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia. 2006;49(3):434-441.
  9. The Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002;346(6):393-403.
  10. Mann D, Carson A, Shimbo D, Fonseca V, Fox C, Muntner P. Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. Adults. Diabetes Care. 2010;33(10):2190-2195.
  11. Bonora E, Tuomilehto J. The Pros and Cons of Diagnosing Diabetes With A1C. Diabetes Care. 2011;34(Supplement_2):S184-S190.
  12. Li G, Zhang P, Wang J, Gregg E, Yang W, Gong Q et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet. 2008;371(9626):1783-1789.
  13. Hamman R, Wing R, Edelstein S, Lachin J, Bray G, Delahanty L et al. Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care. 2006;29(9):2102-2107.
  14. Carr D, Utzschneider K, Boyko E, Asberry P, Hull R, Kodama K et al. A Reduced-Fat Diet and Aerobic Exercise in Japanese Americans With Impaired Glucose Tolerance Decreases Intra-Abdominal Fat and Improves Insulin Sensitivity but not  -Cell Function. Diabetes. 2005;54(2):340-347.
  15. Lindstrom J. Prevention of Diabetes Mellitus in Subjects with Impaired Glucose Tolerance in the Finnish Diabetes Prevention Study: Results From a Randomized Clinical Trial. Journal of the American Society of Nephrology. 2003;14(90002):108S-113.
  16. Gong Q, Kang J, Ying Y, Li H, Zhang X, Wu Y et al. Lifestyle Interventions for Adults with Impaired Glucose Tolerance: A Systematic Review and Meta-Analysis of the Effects on Glycemic Control. Internal Medicine. 2015;54(3):303-310.
  17. Lim E, Hollingsworth K, Aribisala B, Chen M, Mathers J, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506-2514.
  18. Xin Y, Davies A, Briggs A, McCombie L, Messow C, Grieve E et al. Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia. 2020;63(10):2112-2122.
  19. The Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study. Obesity. 2014;22(1):5-13.

 

For membership questions and public speaking enquiries, please get in touch